Intrinsiqq
Safe Orthopaedics SA logo

Safe Orthopaedics SA Quality Score

ALSAF.XPAR

⊜ Compare
Quality15

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-27.3x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-59.2x

Negative FCF, no valuation support

Revenue Growth
0/100
-2.9%

Below 2%, essentially flat

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
257343.6%

Heavy dilution above 5%

Margin Trend
100/100
+36.4pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
€13M

Positive debt with no FCF to service it

2022
€302000
€10.0M
2023
€780000
€271M
2024
€317000
€12.0M
2025
€390000
€14.0M
CashDebt
Return on Capital
0/100
-22.1%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Safe Orthopaedics SA (ALSAF.XPAR) quality: score, margins and returns

Safe Orthopaedics SA (ALSAF.XPAR) scores 15/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -65.9% operating margins and -22.1% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Safe Orthopaedics SA (ALSAF.XPAR) a high-quality business?+

Safe Orthopaedics SA scores 15 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -65.9% operating margin and a -22.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Safe Orthopaedics SA's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from ALSAF.XPAR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Safe Orthopaedics SA scores well and where it falls behind.

What is Safe Orthopaedics SA's return on invested capital (ROIC)?+

Safe Orthopaedics SA earns about -22.1% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to ALSAF.XPAR's margins and growth on this scorecard to judge durability.

How profitable is Safe Orthopaedics SA?+

Safe Orthopaedics SA runs an operating margin of about -65.9% and a net margin of about -87.1%. Revenue has grown at roughly 4.1% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on ALSAF.XPAR: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Peers

Medical Instruments & Supplies · Pick stocks to compare with ALSAF.XPAR

CompareIntrinsic value
ALDVI.XPARAdvicenne S.A.
€0.63-4.26%30
MAAT.XPARMaaT Pharma
€1.02+0.00%40
AFME.XPARAffluent Medical S.A.
€5.28-0.75%0
CVX.XPARCarvolix SA
€5.28-0.75%0
ABNX.XPARAbionyx Pharma SA
€1.57+0.13%0
ABLD.XPARABL Diagnostics S.A.
€2.48+0.00%46
ALSGD.XPARSpineguard S.A.
€0.09-0.56%10
ALINS.XPARIntrasense S.A.
€0.21+0.00%0

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALSAF.XPAR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.